| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Jagdeep Grewal B.Sc., M.B.A., M.Sc. CEO | LSE Exchange | GB00B1VCP282 ISIN |
| United Kingdom Country | 91 Employees | - Last Dividend | - Last Split | - IPO Date |
Cambridge Nutritional Sciences plc is a prominent player in the development, manufacture, and distribution of medical diagnostics products, targeting the food sensitivity testing market. The company's roots trace back to 1987, and it holds a strong presence in London, United Kingdom, with a name change from Omega Diagnostics Group PLC to Cambridge Nutritional Sciences plc in September 2023. Through its subsidiaries, it partakes in extensive research and development, leading to the production of kits aimed at detecting immune reactions to various foods under the brand name Foodprint. Serving a diverse clientele that includes government entities, private hospitals, laboratories, and healthcare professionals across the globe, the company stands as an essential contributor to nutritional sciences and healthcare.
Cambridge Nutritional Sciences plc also provides clinical analysis services to the general public, clinics, and healthcare professionals, elevating the company's status in the medical diagnostics and healthcare sectors. Operating across various geographical locations including the United Kingdom, Europe, North and South America, India, other Asian countries, the Far East, Africa, and the Middle East, the company's product range and services have a global reach, addressing wide-ranging healthcare needs and contributing significantly to the fields of nutrition and medical diagnostics.